M200
This is an old revision of this page, as edited by Jayjay (talk | contribs) at 23:01, July 14, 2007. It may differ significantly from current revision.
M200 was a monoclonal antibody that was being studied in the treatment of some types of cancer. Monoclonal antibodies is made in the laboratory and can locate and bind to cancer cells. M200 binds to a protein that was found on cells that line some tumor blood vessels. It belongs to the family of drugs called angiogenesis inhibitors.
M200 was also called volociximab.